FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Senator John Kennedy introduces America to ‘Margaret,’ his elliptical trainer named after Thatcher

Waymo driverless cars overrun Atlanta neighborhood, circling cul-de-sacs and alarming families with kids

Lithuania and Poland forecast ‘military aid’ to help open Strait of Hormuz amid denials of US troop reductions in region

From Revival to Reformation: Why I’m Running for Governor of California

Here’s Where the Redistricting Wars Stand as the 2026 Midterms Approach

Trump Urged to Address Plight of Persecuted Chinese Minorities During Beijing Visit

In the Battle for School Choice, Families Get Stuck in the Middle

Fox News Campus Radicals Newsletter: Detransitioner drama, sex toy giveaways, shocking bathroom find

Former Christian school teacher sentenced after pleading guilty to child seduction charge

Colorado governor commutes Tina Peters’ sentence as Trump posts ‘FREE TINA!’

Supreme Court deals blow to Virginia Democrats in fight over state court ruling

Eric Trump Announces Lawsuit Against Jen Psaki, MS NOW for ‘Blatant Lies’ About China Business Ties

Navy veteran Rocky Rochford seeks to turn Tampa Bay red, unseat 20-year House incumbent

Trump Reveals Waterfront Site for Long-Planned National Garden of American Heroes

Minnesota Medicaid operator’s bankruptcy-to-riches rise crashes into fraud probe

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”